3RD-GENERATION ORAL-CONTRACEPTIVES - HOW RISKY

被引:28
作者
WEISS, N
机构
[1] Department of Epidemiology, University of Washington, Seattle, WA
来源
LANCET | 1995年 / 346卷 / 8990期
关键词
D O I
10.1016/S0140-6736(95)91921-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1570 / 1570
页数:1
相关论文
共 8 条
[1]   ORAL-CONTRACEPTIVE ESTROGEN AND PROGESTIN POTENCIES AND THE INCIDENCE OF DEEP VENOUS THROMBOEMBOLISM [J].
GERSTMAN, BB ;
PIPER, JM ;
FREIMAN, JP ;
TOMITA, DK ;
KENNEDY, DL ;
FERGUSON, WJ ;
BENNETT, RC .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (04) :931-936
[2]  
HELMRICH SP, 1987, OBSTET GYNECOL, V69, P91
[3]  
KAY CR, 1982, AM J OBSTET GYNECOL, V142, P762
[4]   PROGESTOGENS AND CARDIOVASCULAR REACTIONS ASSOCIATED WITH ORAL-CONTRACEPTIVES AND A COMPARISON OF THE SAFETY OF 50-MU-G AND 30-MU-G ESTROGEN PREPARATIONS [J].
MEADE, TW ;
GREENBERG, G ;
THOMPSON, SG .
BRITISH MEDICAL JOURNAL, 1980, 280 (6224) :1157-1161
[5]  
SPEROFF L, 1993, OBSTET GYNECOL, V81, P1034
[6]   ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE .2. [J].
STADEL, BV .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (12) :672-677
[7]   INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR-V LEIDEN MUTATION [J].
VANDENBROUCKE, JP ;
KOSTER, T ;
BRIET, E ;
REITSMA, PH ;
BERTINA, RM ;
ROSENDAAL, FR .
LANCET, 1994, 344 (8935) :1453-1457
[8]   ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLISM - FINDINGS IN A LARGE PROSPECTIVE-STUDY [J].
VESSEY, M ;
MANT, D ;
SMITH, A ;
YEATES, D .
BRITISH MEDICAL JOURNAL, 1986, 292 (6519) :526-526